Table 1 Characteristics and functional outcome of the sample participants according to income level
Variables | Total no./total (%) | Family average monthly income ≤ RMB 260 no./total (%) | Family average monthly income > RMB260 no./total (%) | P |
|---|---|---|---|---|
Sociodemographic characteristics | ||||
Male gender | 271/425(63.8) | 146/224(65.2) | 125/201(62.2) | 0.52 |
Age of occurrence,years | 60.7 ± 11.4 | 61.2 ± 11.1 | 60.1 ± 11.7 | 0.33a |
  < 65 | 265/415(63.9) | 136/218(62.4) | 129/197(65.5) | 0.51 |
Marital status | ||||
 Married | 319/425(75.1) | 166/224((74.1) | 153/201((76.1) | 0.63 |
 Unmarried/devorced/widowed | 106/425(24.9) | 58/224(25.9) | 48/201(23.9) |  |
Living alone | 25/425(5.9) | 16/224(7.1) | 9/201(4.5) | 0.24 |
Unemployed/retired | 303/425(71.3) | 162/224(72.3) | 141/201(70.1) | 0.62 |
Comorbidities and risk factors | ||||
Hypertension | 341/425(80.2) | 181/224(80.8) | 160/201(79.6) | 0.76 |
 Use of anti-hypertensive drugs | 245/341(71.8) | 132/181(72.9) | 113/160(70.6) | 0.64 |
 Control of hypertension | 55/296(18.6) | 25/149(16.8) | 30/147(20.4) | 0.42 |
Diabetes mellitus | 71/425(16.7) | 34/224(15.2) | 37/201(18.4) | 0.37 |
 Use of hypoglycemic drugs | 50/71(70.4) | 23/34(67.6) | 27/37(73.0) | 0.62 |
 Control of fasting blood glucose | 7/71(9.9) | 5/34(27.8) | 2/37(7.7) | 0.17 |
Hyperlipidaemia | 88/425(20.7) | 45/224(20.1) | 43/201(21.4) | 0.74 |
 Use of lipid-lowering drugs | 33/88(37.5) | 13/45(28.9) | 20/43(46.5) | 0.09 |
Artrial fibrillation | 12/425(2.8) | 7/224(3.1) | 5/201(2.5) | 0.69 |
 Use of anticoagulant drugs | 0/12 | 0/7 | 0/5 |  |
Coronary heart diseases | 39/425(9.2) | 19/224(8.5) | 20/201(10.0) | 0.60 |
No comorbidities | 79/425(18.6) | 39(17.4) | 40(19.9) | 0.51 |
Family history | 60/425(14.1) | 27/224(12.1) | 33/201(16.4) | 0.20 |
Current smoking | 67/425(15.8) | 31/224(13.8) | 36/201(17.9) | 0.25 |
Current alcohol consumption | 11/425(2.6) | 5/224(2.2) | 6/201(3.0) | 0.63 |
Stroke care services | ||||
Stroke type | ||||
 Ischemic stroke | 291/425(68.5) | 139/224(62.0) | 152/201(75.6) | 0.001 |
 Hemorrhagic stroke | 90/425(21.2) | 51/224(22.8) | 39/201(19.4) |  |
 Unknown | 44/425(10.4) | 34/224(15.2) | 10/201(5.0) |  |
Neuroimaging diagnosis | ||||
 CT brain scan | 380/425(89.4) | 190/224(84.8) | 190/201(94.5) | 0.001 |
 MRI brain scan | 142/425(33.4) | 63/224(28.3) | 79/201(39.3) | 0.02 |
 None | 44/425(10.4) | 34/224(15.2) | 10/201(5.0) | 0.001 |
Course of stroke,years | 4.0(2.0,6.0) | 4.0(2.0,6.0) | 4.0(2.0,6.0) | 0.99c |
Previous stroke | ||||
 0 | 291/425(68.5) | 146/224(65.2) | 145/201(72.1) | 0.28 |
 1 | 89/425(20.9) | 53/224(23.7) | 36/201(17.9) |  |
  ≥ 2 | 45/425(10.6) | 25/224(11.2) | 20/201(10.0) |  |
Awareness of stroke warning signd | 196/425(46.1) | 104/224(46.4) | 92/201(45.8) | 0.89 |
Time from onset to emergency room (hours) | ||||
  ≤ 2 | 205/409(50.1) | 107/215(49.8) | 98/194(50.5) | 0.71 |
 2–6 | 103/409(25.2) | 53/215(24.7) | 50/194(25.8) |  |
 6–24 | 36/409(8.8) | 17/215(7.9) | 19/194(9.8) |  |
  > 24 | 65/409(15.9) | 38/215(17.7) | 27/194(13.9) |  |
Use of emergency ambulance | 98/425(23.1) | 58/224(25.0) | 42/201(20.9) | 0.32 |
Level of hospital admitted | ||||
 1 | 105/415(25.3) | 54/218(24.8) | 51/197(25.9) | 0.04 |
 2 | 250/415(60.2) | 141/218(64.7) | 109/197(55.3) |  |
 3 | 60/415(14.5) | 23/218(10.6) | 37/197(18.8) |  |
Ischemic stroke | ||||
 Intravenous thrombolysis | 6/291(2.1) | 1/139(0.7) | 5/152(3.3) | 0.26b |
 Antiplatelet therapy after discharge(Aspirin) | 107/291(36.8) | 51/139(36.7) | 56/152(36.8) | 0.98 |
 Antiplatelet Therapy after discharge(Clopidogrel) | 7/291(2.4) | 2/139(1.4) | 5/152(3.3) | 0.52 |
Hemorrhagic stroke | ||||
 Surgery | 26/90(28.9) | 14/51(27.5) | 12/39(30.8) | 0.73 |
Rehabilitation | 187/425(44.0) | 99/224(44.2) | 88/201(43.8) | 0.93 |
Duration of rehabilitation(weeks) | ||||
  < 4 | 94/174(54.0) | 45/89(50.6) | 49/85(57.6) | 0.54c |
 4–8 | 24/174(13.8) | 15/89(16.9) | 9/85(10.6) |  |
 8–12 | 5/174(2.9) | 3/89(3.4) | 2/85(2.4) |  |
  > 12 | 51/174(29.3) | 26/89(29.2) | 25/85(29.4) |  |
Inhospitalization in previous year | 106/425(24.9) | 50/224(22.3) | 56/201(27.9) | 0.19 |
Outpatient attendance in previous month | ||||
 Level 1 hospital | 88/425(20.7) | 41/224(18.3) | 47/201(23.4) | 0.20 |
 Level 2–3 hospital | 30/425(7.1) | 9/224(4.0) | 21/201(10.4) | 0.01 |
Modified Rankin Scale Score | ||||
 0–2 | 209/425(49.1) | 83/224(37.1) | 126/201(62.7) | < 0.001 |
 3–5 | 216/425(50.9) | 141/224(62.9) | 75/201(37.3) |  |